Somogyi L, Török A, Bors G, Drinóczy M, Horváth R
Orv Hetil. 1989 Mar 26;130(13):671-3.
The authors report on experiences of treatment for superficial bladder cancer with BCG have achieved during three years. To achieve a permanent recidive prophylaxis the 6 weeks long course was repeated yearly. During the 37-12 months follow up a tumor recurrence have been observed in 10 of 49 patients (20.4%). There have not been seen any serious side-effects requering the interruption of the course or requering any antituberculotica. On the basis of their results and the torelable side-effects they recommend the local BCG treatment as a favourable possibility in prevention of bladder tumor recurrence.
作者报告了三年来用卡介苗治疗浅表性膀胱癌的经验。为实现永久性复发预防,每年重复为期6周的疗程。在37至12个月的随访中,49例患者中有10例(20.4%)出现肿瘤复发。未观察到任何需要中断疗程或需要使用抗结核药物的严重副作用。基于他们的结果和可耐受的副作用,他们推荐局部卡介苗治疗作为预防膀胱肿瘤复发的一种有利方法。